Invesco DB Oil Fund vs Moderna, Inc. — how do they compare? Invesco DB Oil Fund trades at $21.05, while Moderna, Inc. trades at $64.24 (market cap $24.18B). Which is the better fit depends on your goals.
| DBO | MRNA | |
|---|---|---|
Sector | Commodities - Energy | Health |
52-Week High | $23.80 | $81.80 |
52-Week Low | $11.98 | $22.36 |
Market Cap | — | $24.18B |
Enterprise Value | — | $20.33B |
Signals from Pluang's Aura AI — not financial advice
DBO trades at $21.03, up 0.86% with a bullish technical signal from moving averages. Recent news highlights oil market volatility due to Middle East tensions and OPEC demand forecast cuts. The stock shows neutral oscillator readings but strong moving average support, indicating underlying strength despite sector headwinds.
The outlook remains cautious due to oil market uncertainties, though technical momentum suggests near-term upside potential. Key risks include geopolitical supply disruptions and demand volatility, while institutional sentiment appears mixed with limited fundamental data available for analysis.
Moderna (MRNA) trades at $63.57, up 6.29% on the day, reflecting positive momentum following FDA approval of its mRNA flu vaccine, mFLUSIVA, for adults 50 and older. The stock exhibits a bullish technical outlook with moving averages supporting upward movement, though RSI levels suggest potential overbought conditions. Fundamentally, revenue has declined from pandemic peaks, with 2025 revenue at $1.92B and a net loss of -$2.82B, yet the company has beaten EPS estimates in recent quarters. Cash flow trends show improvement, with net cash flow turning positive in 2025 at $668M.
The outlook for MRNA hinges on pipeline execution beyond COVID-19, with recent vaccine approvals providing growth catalysts. Investment opportunities include diversification into flu, Ebola, and oncology therapies, but risks persist from high cash burn, competitive pressures, and reliance on successful clinical trials. Analyst sentiment is mixed with a consensus price target of $54.33, below the current price, indicating caution despite some bullish developments.
Trailing returns across standard periods
DBO provides exposure to WTI crude oil prices through futures contracts. It is designed for investors seeking a way to invest in the performance of the fossil fuel market without purchasing physical oil barrels.
Read more on DBO →Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →